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Toll-like receptor 9 (TLR9) requires proteolytic maturation to acquire signaling capacity; however, the
involved protease(s) is unclear. In this issue of Immunity, Sepulveda et al. (2009) demonstrate that in dendritic
cells, asparaginyl endopeptidase is a key protease that controls TLR9 maturation.Toll-like receptors (TLRs) recognize
conserved molecular patterns expressed
by pathogens and trigger a comprehen-
sive defensive response (Barton and
Kagan, 2009). This response includes
production of proinflammatory cytokines,
activation of antigen-presenting cells
associated with expression of costimula-
tory molecules and reorganization of the
cytoskeleton, and initiation of an adaptive
immune response. Whereas TLRs ex-
pressed at the cell surface mainly recog-
nize lipidated moieties such as glycolipids
(TLR2), lipopeptides (TLR1, 2, 6), or
lipopolysaccharide (TLR4), TLRs recog-
nizing nucleic acids (TLR3, 7, 8, 9) are
confined to endocytic compartments
where they encounter ligands internalized
via receptor-mediated endocytosis or
phagocytosis. Intracellular segregation
of these TLRs is thought to provide one
level of protection from autoimmunity,
which could result if cell surface TLRs
bind self nucleic acids released during
apoptotic or necrotic cell death. A second
level is added by the ligand specificity of
TLR9, a receptor expressed strongly by
macrophages, dendritic cells (DCs; pref-
erentially plasmacytoid DCs), and B
lymphocytes, which recognizes unmethy-
lated CpG (umCpG) motifs frequent in
bacterial but rare in vertebrate DNA.
Recent studies in two laboratories have
uncovered a third safeguard against
unwanted triggering of innate immune
responses by TLR9 receptors leaking to
the cell surface: full-length TLR9 recep-
tors traveling from the endoplasmic retic-
ulum to endosomes must undergo
proteolytic maturation in an acidic envi-
ronment to become competent for sig-
naling (Ewald et al., 2008; Park et al.,
2008). Analyzing proteolytic TLR9 matu-
ration, the two studies failed to clearly
identify the protease(s) responsible for696 Immunity 31, November 20, 2009 ª2009TLR9 cleavage, and concluded that TLR9
cleavage likely is carried out by a redun-
dant array of endolysosomal proteases.
However, the findings reported by Sepul-
veda et al. (2009) in this issue of Immunity
suggest that TLR9 cleavage may follow
a pathway less redundant than previously
thought.
The importance of a proteolytic endoly-
sosomal environment for TLR9 signaling
was recognized before TLR9 itself was
shown to undergo proteolytic maturation.
Thus, drugs inhibiting endolysosome
acidification, which is required for activa-
tion of acid proteases, inhibit TLR9 signal-
ing (Ewald et al., 2008; Park et al., 2008;
Sepulveda et al., 2009 [this issue]). Lyso-
somes contain a broad array of prote-
ases, most of them cathepsins belonging
to the cysteine protease group. Although
cysteine protease inhibitors with broad
specificity inhibit both TLR9 cleavage
and signaling (Park et al., 2008), experi-
ments with more specific inhibitors have
produced partly contradictory results.
Several inhibitors, including general
cathepsin B and L inhibitors as well as
a presumably highly specific cathepsin K
inhibitor, were reported to block TLR9
signaling (Asagiri et al., 2008; Matsumoto
et al., 2008). However, more recent
studies with both inhibitors and gene-
targeted mice could not confirm a role
for cathepsin K in TLR cleavage and/or
signaling (Ewald et al., 2008; Park et al.,
2008), suggesting that off-target effects
may have played a role in the older
studies. With respect to other cathepsins,
one study could not observe an effect of
genetic deficiency or pharmacological
inhibition of cathepsins S, L, or B on TLR
function (Ewald et al., 2008), whereas
a second study reported partial inhibition
of umCpG-induced cytokine production
in cathepsin S- and L-deficient DCsElsevier Inc.(Park et al., 2008). This correlated with
appearance of a putative TLR9 proteolytic
intermediate with a molecular weight
slightly above that of the (presumably)
active TLR9 fragment; however, the func-
tional competence of this intermediate
remains unclear. Although inhibitor studies
produced partly conflicting results, this is
not the case for in vitro digestion studies
with purified cathepsins in which all
authors found efficient cleavage of TLR9
by a number of proteases including
cathepsins K, L, and S (Ewald et al.,
2008; Park et al., 2008; Sepulveda et al.,
2009). Thus, various cathepsins appar-
ently can activate TLR9 proteolytically
under appropriate conditions, but no
single cathepsin seems indispensable for
TLR9 activation.
Not discouraged by the redundancy in
endolysosomal proteolysis, Sepulveda
et al. (2009) set out to examine a potential
role of their favorite protease, asparaginyl
endopeptidase (AEP). AEP is another
cysteine protease cleaving specifically
after asparagine that itself undergoes
partly autocatalytic proteolytic maturation
upon reaching acidic compartments,
similar to cathepsins (Li et al., 2003). AEP
had previously come to prominence
because of its nonredundant role as
‘‘upstream’’ protease in sequential degra-
dation of several antigens, including
tetanus toxoid and myelin basic protein,
for presentation by MHC class II mole-
cules (Watts et al., 2005). In the present
study by Sepulveda et al. (2009), first
evidence for an important role of AEP in
TLR9 cleavage is obtained in in vitro diges-
tions in which both a specific inhibitor and
genetic deficiency for AEP reduce TLR9
processing by DC lysates greatly, a result
in striking contrast with the failure to
detect such effects in similar experiments
targeting various cathepsins (Ewald et al.,
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phagosomes and find that TLR9 cleavage
occurs at late time points in wild-type
phagosomes devoid of TLR9 ligands, but
is dramatically accelerated by umCpG
oligonucleotides. In the absence of AEP,
TLR9 cleavage occurs exclusively in
umCpG-treated DCs and at late time
points. Further analysis of umCpG-treated
DCs shows that rapid appearance of
cleaved TLR9 in size-separated protein
fractions also containing the signaling
adaptor MyD88, presumably reflecting
previously described TLR9-MyD88 com-
plexes, depends on AEP. Appearance of
cleaved TLR9 is associated with rapid en-
dosomal acidification and enhanced AEP
activity. Collectively, these results provide
strong evidence for a requirement of AEP
in rapid ligand-induced cleavage and
MyD88 association of TLR9.
If AEP is required for proteolytic TLR9
activation, then AEP-deficient DCs and
mice should display compromised
responses to TLR9 ligands. Indeed, Se-
pulveda et al. (2009) demonstrate that
AEP deficiency results in reduced secre-
tion of the proinflammatory cytokines
TNF-a, IL-6, and IL-12 by conventional
DCs, as well as strongly reduced IFN-
a secretion by plasmacytoid DCs, which
play a unique and critical role by rapidly
secreting large amounts of type I IFNs
in response to umCpG DNA in vivo.
Importantly, AEP-deficient macrophages
respond normally to umCpG DNA, sug-
gesting that the critical role of the
protease is limited to DCs. In vivo, AEP
deficiency greatly compromises early
umCpG-stimulated secretion of IL-6 and
IL-12 as well as proliferation of CD4+
T cells primed in the presence of umCpG
DNA, which in this context is used as
adjuvant. Thus, both biochemical and
functional data document the impact of
AEP deficiency on TLR9 maturation and
signaling.
Although at first sight these findings
seem sufficient evidence for direct
proteolytic production of signaling-
competent TLR9 by AEP, Sepulveda
et al. (2009) faced an obstacle compli-
cating data interpretation. It had previ-
ously been described that AEP deficiency
abrogates proteolytic conversion of
cathepsins B and L from the single-chain
to the mature two-chain forms, an obser-
vation confirmed by Sepulveda et al.
(2009) (Maehr et al., 2005; Shirahama-
Noda et al., 2003). Could the effect of
AEP deficiency on TLR9 cleavage result
from its effect on cathepsin maturation?
Not so, as demonstrated quite convinc-
ingly by the authors. With active site
probes and assays measuring the
cleavage of fluorogenic substrates, the
concerned cathepsins are shown to
display normal or even enhanced activity.
Most importantly, transfection of TLR9-
deficient DCs with a mutant TLR9 form
lacking a putative AEP cleavage site does
not restore TLR9 signaling, suggesting
that TLR9 is a direct substrate for AEP.
Where do these results place AEP in
proteolytic activation of TLR9? There is
certainly more than one pathway to
TLR9 activation (Figure 1). In macro-
phages, early and strong acidification of
endosomes or phagosomes results in
rapid activation of cathepsins that are
sufficient to cleave and activate TLR9,
which obviates the requirement of AEP.
In DCs, which display retarded and
reduced acidification of endosomes or
phagosomes, AEP is required for efficient
TLR9 cleavage, possibly favored by its
earlier recruitment to endocytic vesicles
relative to cathepsins. In the absence of
AEP, the latter can substitute for it, but
with strongly delayed kinetics because
of their later recruitment and/or stronger
dependence on an acidic pH. Stepwise
cleavage in which cathepsins S or L act
downstream of AEP is also conceivable.
Whatever the precise sequence of
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Figure 1. Proteolytic TLR9 Maturation in Macrophages and Dendritic Cells
Early phagosomes with a near-neutral pH containing pathogens (in blue) fuse with endosomes harboring
full-length TLR9 receptors. In macrophages, rapid phagosome acidification (indicated by dark red color)
together with recruitment of cathepsins results in AEP-independent TLR9 cleavage and signaling via
MyD88 after binding of umCpG DNA. In DCs, early recruitment of AEP to phagosomes initiates TLR9
cleavage, activation, and MyD88-mediated signaling. Further TLR9 activation and signaling through the
parallel or sequential action of AEP and cathepsins may occur in mildly acidic late phagosomes.Immunity 31, November 20, 2009 ª2009 Elsevier Inc. 697
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Previewscleavages, the important role of AEP in
TLR9 signaling in DCs suggests that the
protease may be an attractive target for
pharmacological intervention in chronic
inflammatory diseases.
Even though the findings of Sepulveda
et al. (2009) are an important advance in
our understanding of TLR9 activation,
many questions remain to be answered.
Although all three relevant studies place
the site of TLR9 cleavage between resi-
dues 441 and 470 in a presumably disor-
dered loop in the ectodomain, the precise
cleavage site remains to be mapped.
Another critical question concerns the
molecular reason for TLR9 cleavage.
Given that full-length and truncated acti-
vated TLR9 both bind CpG DNA (though
with somewhat different affinity), proteo-
lytic cleavage may be required to allow
for conformational changes and/or TLR9
interaction with other proteins. Moreover,
much remains to be elucidated withNever Underestim
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capable of phagocytosing pathoge
(2009) shed fresh light on the plasti
It is well known that polymorphonuclear
neutrophil leukocytes (PMNs) provide a
first line of defense against invading
pathogens by producing a wide range of
effector molecules essential for pathogen
killing (Nathan, 2006). In this issue of
Immunity, Zhang et al. (2009) report that
murine PMN might also display a pre-
viously unsuspected immunoregulatory
role during acute and chronic microbial
infections, thus extending current under-
standing in the field of PMN-derived
functions in response to PRR and other
microbial receptors.
698 Immunity 31, November 20, 2009 ª200respect to TLR9 trafficking. Given that
only small amounts of full-length TLR9
reside in endosomes of steady-state
DCs, what signals trigger recruitment of
additional receptors to endolysosomes?
Although a positive-feedback mechanism
is conceivable, a role of additional nucleic
acid receptors cannot be ruled out.
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powerful cytotoxic equipment, PMNs
have a major role in inflammatory re-
sponses. Indeed, when released in an
uncontrolled manner, as observed in
inflammatory diseases dominated by
PMNs, PMN-derived ROS and proteases
may also damage the surrounding tissues
(Nathan, 2006). However, increasing evi-
dence suggests that PMN are remarkably
versatile cells, whose functions go far be-
yond phagocytosis and pathogen killing.
For instance, exposure to an inflammatory
milieu dramatically increases the life span
of PMNs, thus giving them a chance to
